We are live on ! Find out more
HA

HC Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 17.72%
This Fund
S&P 500
This Quarter Est. Return
-3.27%
1 Year Est. Return
+17.72%
3 Year Est. Return
+55.19%
5 Year Est. Return
+59.33%
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$4.81M
Cap. Flow
+$12.4M
Cap. Flow %
8.52%
Top 10 Hldgs %
55.1%
Holding
87
New
7
Increased
40
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$3.37M
2
APLS
Apellis Pharmaceuticals
APLS
+$2.02M
3
IYF icon
iShares US Financials ETF
IYF
+$1.51M
4
VDE icon
Vanguard Energy ETF
VDE
+$1.31M
5
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
+$904K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.29M
2
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$487K
3
VONV icon
Vanguard Russell 1000 Value ETF
VONV
+$281K
4
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$265K
5
XOM icon
ExxonMobil
XOM
+$215K

Sector Composition

Rank Sector Weight
1 Healthcare 7.38%
2 Technology 2.82%
3 Financials 1.9%
4 Industrials 1.05%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWF icon
51
iShares Russell 1000 Growth ETF
IWF
$120B
$465K 0.32%
8,840
– –
VTV icon
52
Vanguard Morningstar Value ETF
VTV
$188B
$446K 0.31%
+3,609
New +$488K
VTWV icon
53
Vanguard Russell 2000 Value ETF
VTWV
$1.29B
$425K 0.29%
3,754
+45
+1% +$5.7K
PAAS icon
54
Pan American Silver
PAAS
$18.6B
$371K 0.26%
23,356
+100
+0.4% +$1.74K
VYM icon
55
Vanguard High Dividend Yield ETF
VYM
$80.9B
$362K 0.25%
3,816
+394
+12% +$41K
BMY icon
56
Bristol-Myers Squibb
BMY
$132B
$343K 0.24%
4,821
-55
-1% -$3.99K
CLDX icon
57
Celldex Therapeutics
CLDX
$3.02B
$341K 0.23%
12,135
+4,510
+59% +$138K
JPM icon
58
JPMorgan Chase
JPM
$933B
$336K 0.23%
3,212
+14
+0.4% +$1.61K
RSP icon
59
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
$335K 0.23%
2,631
+287
+12% +$40.5K
VBK icon
60
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$332K 0.23%
1,702
+3
+0.2% +$644
AON icon
61
Aon
AON
$78.3B
$319K 0.22%
1,192
– –
UNH icon
62
UnitedHealth
UNH
$383B
$301K 0.21%
596
+147
+33% +$77.3K
SCHO icon
63
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$299K 0.21%
12,392
-19,930
-62% -$487K
AXP icon
64
American Express
AXP
$228B
$285K 0.2%
2,109
+1
+0% +$151
SDY icon
65
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$281K 0.19%
2,523
+16
+0.6% +$1.97K
ASND icon
66
Ascendis Pharma A/S
ASND
$16.5B
$266K 0.18%
2,575
-71
-3% -$6.73K
GOOG icon
67
Alphabet (Google) Class C
GOOG
$4.08T
$256K 0.18%
2,660
– –
SPPP
68
Sprott Physical Platinum and Palladium Trust
SPPP
$587M
$250K 0.17%
17,464
– –
JNJ icon
69
Johnson & Johnson
JNJ
$617B
$243K 0.17%
1,490
– –
WM icon
70
Waste Management
WM
$90.9B
$240K 0.17%
1,500
– –
TINV.U
71
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$230K 0.16%
21,704
– –
SRPT icon
72
Sarepta Therapeutics
SRPT
$1.64B
$226K 0.16%
+2,042
New +$206K
DAL icon
73
Delta Air Lines
DAL
$58.3B
$225K 0.15%
8,004
– –
TFC icon
74
Truist Financial
TFC
$63.5B
$225K 0.15%
5,170
+3
+0.1% +$144
VIG icon
75
Vanguard Dividend Appreciation ETF
VIG
$112B
$203K 0.14%
1,500
– –
1 2
3
4

Similar funds

ZC
Zeit Capital Greenwood Village, Colorado $149M AUM 15.63% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $149M AUM
SWM
Sagace Wealth Management St. Petersburg, Florida $149M AUM 12.7% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return
AIA
Accelerate Investment Advisors Aliso Viejo, California $150M AUM 17.82% 1-Year Est. Return
TWM
Thryve Wealth Management Irving, Texas $150M AUM
E
Evansbrook Bolingbrook, Illinois $150M AUM
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return

HC Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, HC Advisors held 87 positions worth $145M, up 3.4% from $140M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

HC Advisors deployed $12.4M of net new capital in Q3 2022, opening 7 new positions and adding to 40 existing holdings. Its largest new stake was Zeta Global: 132,789 shares worth $878K.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 3.2% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $1.29M trimmed.

  • HC Advisors's largest Q3 2022 buy was Zeta Global: 132,789 shares worth $878K.
  • HC Advisors added most to CRISPR Therapeutics in Q3 2022, an estimated $3.37M increase.
  • HC Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $1.29M.
  • HC Advisors fully exited ExxonMobil in Q3 2022, selling an estimated $215K.
  • HC Advisors's ten largest holdings make up 55% of its $145M portfolio in Q3 2022.
  • HC Advisors opened 7 new positions and closed 2 in Q3 2022.
  • HC Advisors's portfolio value rose 3.4% quarter-over-quarter to $145M.

Based on HC Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.